Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -4.36%8.16B | 6.34%8.72B | 6.90%9.39B | 0.91%11.44B | -9.64%8.53B | -1.18%8.2B | -3.38%8.78B | 21.99%11.34B | 32.85%9.44B | 24.70%8.3B |
Transactional financial assets | 60.00%320M | -89.09%60M | -34.55%360M | -10.00%360M | -76.47%200M | -58.02%550M | -33.74%550M | -50.26%400M | 54.55%850M | --1.31B |
Notes receivable and accounts receivable | 3.22%7.11B | -5.18%6.44B | 0.01%5.9B | 13.38%6.6B | 61.95%6.89B | 84.72%6.79B | 57.22%5.89B | 22.06%5.82B | 26.11%4.25B | 5.47%3.67B |
-Notes receivable | 89.61%10.92M | -83.28%2.27M | -79.78%2.27M | -85.25%1.43M | -38.12%5.76M | 115.10%13.57M | -59.15%11.22M | -67.38%9.66M | -68.96%9.31M | -86.99%6.31M |
-Accounts receivable | 3.14%7.1B | -5.02%6.43B | 0.16%5.89B | 13.55%6.6B | 62.17%6.88B | 84.67%6.77B | 58.07%5.88B | 22.62%5.81B | 26.97%4.24B | 6.77%3.67B |
Other receivables (including interest and dividends) | -1.81%1.95B | -11.08%1.86B | -3.04%1.8B | 9.78%1.89B | 10.38%1.98B | 17.99%2.09B | 16.02%1.85B | 14.17%1.72B | 2.35%1.8B | 1.16%1.77B |
-Dividend receivable | --2.88M | --2.88M | --2.88M | --2.88M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other receivable | ---- | -11.21%1.86B | ---- | ---- | ---- | 17.99%2.09B | ---- | --1.72B | ---- | 1.16%1.77B |
Contractual assets | 24.05%32.21B | 24.30%29.99B | 30.37%26.86B | 25.56%27.89B | 11.69%25.96B | 11.81%24.13B | 5.89%20.6B | 2.96%22.21B | 35.58%23.25B | 47.64%21.58B |
Advance payment | 23.48%692.81M | 70.43%486.46M | 13.71%418.68M | -4.46%288.17M | -43.69%561.06M | -54.97%285.43M | -36.97%368.19M | -8.73%301.61M | 71.81%996.42M | 65.29%633.92M |
Inventories | -13.61%1.93B | -12.68%1.87B | 1.55%1.89B | 9.57%1.84B | 3.89%2.23B | 0.39%2.14B | -4.78%1.86B | -18.43%1.68B | 4.41%2.15B | 24.79%2.13B |
Receivable financing | 76.82%152.36M | 136.00%76.88M | 1,236.76%266.62M | 57.55%108.85M | -84.65%86.17M | -88.33%32.58M | -94.15%19.95M | -83.96%69.09M | 7.86%561.4M | -28.75%279.25M |
Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Non-current assets due within one year | -15.01%448.8M | 3.87%538.98M | 1.79%511.07M | -2.94%512.28M | 39.07%528.07M | 58.11%518.91M | 28.37%502.1M | 33.40%527.78M | -11.18%379.72M | -23.23%328.19M |
Other current assets | 6.22%1.67B | -17.53%1.57B | -29.74%1.3B | -3.22%1.64B | -7.12%1.57B | 18.20%1.91B | -17.67%1.86B | -11.23%1.7B | 6.60%1.69B | 0.63%1.61B |
Total current assets | 12.55%54.64B | 10.66%51.61B | 15.13%48.68B | 14.87%52.57B | 7.01%48.55B | 12.06%46.64B | 5.08%42.28B | 6.25%45.77B | 29.23%45.37B | 34.17%41.62B |
Non Current assets | ||||||||||
Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other equity investment | 30.22%1.26B | 38.16%1.26B | 36.58%1.2B | 34.82%1.17B | 36.65%967.03M | 30.12%909.29M | 66.91%877.02M | 89.69%865.57M | 55.43%707.69M | 126.24%698.81M |
Investment real estate | 357.80%36.96M | 362.58%39.07M | -10.57%7.89M | 22.98%8.32M | 11.25%8.07M | 11.53%8.45M | 13.17%8.82M | -8.57%6.77M | -11.96%7.26M | -10.67%7.57M |
Long-term equity investment | 27.90%2.52B | 34.32%2.5B | 17.23%2.16B | 27.13%2.07B | 39.35%1.97B | 35.43%1.86B | 53.17%1.85B | 52.89%1.62B | 60.40%1.41B | 77.73%1.38B |
Long term receivable account | 87.84%780.25M | 72.89%784.59M | 69.16%785.09M | 112.75%936.96M | -47.68%415.37M | -42.84%453.81M | -37.45%464.11M | -40.65%440.41M | -73.86%793.96M | -71.51%793.96M |
Fixed assets | ---- | 34.32%3.19B | ---- | ---- | ---- | 30.45%2.38B | ---- | --2.31B | ---- | -45.57%1.82B |
Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Constru in process | ---- | -71.60%297.1M | ---- | ---- | ---- | 18.39%1.05B | ---- | --779.67M | ---- | 55.89%883.67M |
Productive biological assets | --2.12M | --1.32M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Intangible assets | -2.48%287.65M | -2.31%289.58M | 5.89%292.8M | -1.88%294.84M | 7.95%294.97M | 7.90%296.42M | -0.88%276.53M | -45.38%300.49M | -54.48%273.24M | -54.80%274.71M |
Development expenditure | ---- | ---- | --240.02K | ---- | ---- | ---- | --0 | ---- | --8.11M | --5.83M |
Long deferred expense | 42.22%178.61M | 51.70%178.57M | 52.34%166.82M | 35.21%155.62M | 14.38%125.59M | 2.41%117.72M | -19.26%109.5M | -7.43%115.09M | 13.14%109.8M | 24.64%114.94M |
Deferred tax assets | 20.92%210.6M | 14.51%194.76M | 40.56%214.09M | 8.25%199M | 29.14%174.16M | 24.62%170.08M | 10.32%152.31M | -8.12%183.82M | 17.08%134.87M | 19.26%136.48M |
Usufruct assets | 62.82%151.5M | 46.09%133.05M | 9.23%125.04M | -9.95%121.99M | -24.30%93.05M | -34.56%91.08M | -35.58%114.47M | -42.08%135.48M | -48.92%122.92M | -46.76%139.18M |
Other non current assets | 32.68%9.13B | 16.70%7.9B | 11.65%7.54B | 27.68%8.22B | 93.49%6.88B | 93.75%6.77B | 142.12%6.75B | 149.39%6.44B | 25.53%3.55B | 2.89%3.49B |
Total non current assets | 25.11%18.03B | 18.91%16.77B | 19.10%16.06B | 27.16%16.78B | 45.68%14.41B | 44.69%14.1B | 57.79%13.49B | 27.48%13.2B | -19.26%9.89B | -20.52%9.75B |
Total assets | 15.42%72.67B | 12.57%68.38B | 16.09%64.75B | 17.62%69.36B | 13.93%62.96B | 18.25%60.74B | 14.31%55.77B | 10.36%58.97B | 16.69%55.26B | 18.67%51.37B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 20.66%7.48B | 28.84%7.15B | 34.08%6.67B | 16.20%6.4B | 17.05%6.2B | -1.27%5.55B | -5.79%4.97B | 11.59%5.51B | 9.23%5.3B | 19.23%5.62B |
Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Notes payable and accounts payable | 19.00%31.56B | 13.87%28.4B | 10.90%24.74B | 20.24%31.05B | 10.19%26.52B | 13.57%24.94B | 12.24%22.31B | 4.08%25.82B | 17.20%24.07B | 24.24%21.96B |
-Notes payable | -78.69%283.46M | -76.66%242.7M | -86.45%274.73M | -65.52%451.57M | -58.39%1.33B | -61.92%1.04B | -22.42%2.03B | -52.53%1.31B | 34.88%3.2B | 72.42%2.73B |
-Accounts payable | 24.16%31.28B | 17.81%28.15B | 20.64%24.47B | 24.83%30.59B | 20.69%25.19B | 24.28%23.9B | 17.49%20.28B | 11.16%24.51B | 14.89%20.87B | 19.50%19.23B |
Contract liabilities | -31.74%1.65B | -39.85%1.52B | 63.14%2.6B | 54.87%1.79B | 52.55%2.42B | 155.26%2.53B | 116.77%1.59B | 37.79%1.16B | 23.24%1.59B | 2.40%991.41M |
Salaries payable | 6.98%131.53M | 12.09%169.01M | 24.89%145.65M | 34.18%169.13M | 3.68%122.96M | 24.67%150.78M | 18.13%116.62M | 13.44%126.05M | 4.29%118.59M | 0.66%120.94M |
Taxs payable | 1.60%381.95M | 6.04%346.61M | -20.39%406.24M | -10.22%482.73M | -5.71%375.94M | 6.64%326.86M | 0.95%510.31M | -6.89%537.69M | 5.19%398.71M | -20.54%306.51M |
Other payable (including interest and dividends) | 34.18%4.28B | 27.40%3.95B | 35.31%3.63B | 11.23%3.02B | 25.82%3.19B | 36.13%3.1B | 17.20%2.68B | 16.68%2.71B | 23.21%2.53B | 18.07%2.28B |
-Dividend payable | --4.8M | --4.8M | --4.8M | --4.8M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | ---- | 27.25%3.95B | ---- | ---- | ---- | 36.13%3.1B | ---- | --2.71B | ---- | 18.07%2.28B |
Non current liabilities due within one year | -17.11%491.14M | -45.66%374.15M | -48.82%617.39M | -59.68%580.36M | -57.78%592.5M | -44.80%688.52M | 220.67%1.21B | 166.70%1.44B | 3,933.03%1.4B | 577.89%1.25B |
Other current liabilities | 40.97%4.11B | 42.80%3.92B | 53.54%3.56B | 41.66%3.72B | 50.70%2.91B | 54.88%2.75B | 36.38%2.32B | 30.26%2.62B | 8.78%1.93B | 6.79%1.77B |
Total current liabilities | 18.30%50.09B | 14.49%45.84B | 18.64%42.37B | 18.24%47.2B | 13.38%42.34B | 16.72%40.03B | 15.72%35.71B | 10.44%39.92B | 20.32%37.34B | 24.10%34.3B |
Current liabilities | ||||||||||
Long term loan | -4.75%5.73B | -5.27%6.07B | 19.44%6.92B | 41.85%6.86B | 49.84%6.02B | 84.58%6.41B | 45.39%5.79B | 37.61%4.84B | 38.94%4.02B | 37.97%3.47B |
Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | -94.41%158.67M |
Long term salaries pay | -9.33%41.3M | -10.11%42.28M | -10.76%43.24M | -11.33%44.35M | -11.38%45.55M | -12.11%47.03M | -12.53%48.46M | -13.17%50.01M | -14.27%51.4M | -14.13%53.51M |
Estimate liabilities | -52.89%2.74M | -40.08%3.67M | 11.60%7.24M | -0.63%7.98M | -4.85%5.81M | -39.03%6.13M | 0.27%6.49M | 12.98%8.03M | 4.87%6.1M | 68.31%10.05M |
Deferred tax liabilities | 23.66%159.25M | 7.32%138.22M | 47.83%155M | 4.00%143.1M | 17.65%128.78M | 17.65%128.78M | -6.02%104.85M | -17.33%137.6M | 13.70%109.46M | 13.70%109.46M |
Long term deferred income | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Lease liabilities | 51.10%64.69M | 32.76%53.71M | -8.54%57.42M | -20.09%60.46M | -42.90%42.81M | -55.05%40.46M | -37.77%62.78M | -40.20%75.66M | -68.75%74.98M | -19.40%90.01M |
Total non current liabilities | -3.86%6B | -4.86%6.31B | 19.39%7.18B | 39.33%7.12B | 46.56%6.24B | 70.30%6.63B | -5.13%6.01B | -24.96%5.11B | -31.24%4.26B | -31.28%3.9B |
Total liabilities | 15.45%56.09B | 11.74%52.15B | 18.75%49.55B | 20.63%54.32B | 16.77%48.58B | 22.18%46.67B | 12.17%41.72B | 4.83%45.03B | 11.74%41.6B | 14.68%38.19B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%2.6B | 0.00%2.6B | 40.00%2.6B | 40.00%2.6B | 40.00%2.6B | 42.33%2.6B | 20.83%1.86B | 34.95%1.86B | 34.95%1.86B | 32.75%1.83B |
Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | -93.66%9.63M |
Capital reserve funds | 0.00%4.36B | 0.00%4.36B | -14.57%4.36B | -15.38%4.36B | -15.30%4.36B | -13.03%4.36B | 37.63%5.1B | 70.03%5.15B | 72.66%5.14B | 68.16%5.01B |
Surplus reserve funds | 20.33%516.87M | 20.33%516.87M | 20.33%516.87M | 20.33%516.87M | 22.97%429.54M | 22.97%429.54M | 22.97%429.54M | 22.97%429.54M | 4.65%349.31M | 4.65%349.31M |
Retained profit | 16.32%7.24B | 16.26%6.91B | 15.85%6.91B | 16.34%6.73B | 17.22%6.23B | 18.72%5.95B | 20.45%5.97B | 26.15%5.78B | 23.35%5.31B | 20.07%5.01B |
Other composite income | -764.59%-5.49M | -764.59%-5.49M | -855.35%-5.49M | -855.35%-5.49M | 22.02%-634.74K | 22.02%-634.74K | 29.43%-574.44K | 29.43%-574.44K | -22,364.92%-814.02K | -22,364.92%-814.02K |
Shareholders equity without minority interests | 8.07%14.71B | 7.87%14.38B | 7.69%14.38B | 7.39%14.2B | 7.50%13.61B | 9.25%13.33B | 25.43%13.35B | 39.30%13.22B | 38.42%12.66B | 35.40%12.2B |
Minority interests | 143.29%1.88B | 149.52%1.85B | 17.99%817.77M | 17.29%839.13M | -22.89%771.2M | -23.33%741.49M | -26.54%693.07M | -27.11%715.44M | 1.83%1B | 0.29%967.12M |
Total shareholder equity | 15.32%16.59B | 15.33%16.23B | 8.20%15.2B | 7.90%15.03B | 5.28%14.38B | 6.85%14.07B | 21.20%14.05B | 33.07%13.93B | 34.87%13.66B | 32.01%13.17B |
Total liabilityies and equity | 15.42%72.67B | 12.57%68.38B | 16.09%64.75B | 17.62%69.36B | 13.93%62.96B | 18.25%60.74B | 14.31%55.77B | 10.36%58.97B | 16.69%55.26B | 18.67%51.37B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.